Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06960967
NA

Effects of Chestnuts on Postprandial Glycaemic Response

Sponsor: Monash University

View on ClinicalTrials.gov

Summary

Nut consumption is known to improve health outcomes, such as reducing the risk of chronic diseases like diabetes, cognitive impairment, and cardiovascular diseases. While most research has focused on walnuts and almonds, there is limited information on the health benefits of chestnuts. Chestnuts are unique among tree nuts due to their high starch and fibre content, along with vitamins E and C, minerals (potassium, phosphorus, magnesium), and polyphenols. Evidence from in vitro and animal studies suggests that chestnuts may positively affect health by regulating the gut microbiome, lowering the glycaemic index, and providing antioxidant benefits. The food industry is also exploring new uses for chestnuts, particularly in gluten-free products, due to their nutritional benefits and good taste. Nonetheless, no research has investigated the health effects of chestnuts in humans. By addressing this gap in the literature, the study may lead to the development of new dietary strategies for improved health outcomes.

Official title: Postprandial Effects of Chestnuts on Glycaemic Response: a Cross-over Trial in Healthy Adults

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2025-06-06

Completion Date

2026-04-30

Last Updated

2026-03-10

Healthy Volunteers

Yes

Interventions

OTHER

Chestnut meal

Participants will receive an isocaloric baked meal with chestnut flour.

OTHER

Control meal

Participants will receive an isocaloric baked meal without chestnut flour.

Locations (1)

Monash University

Melbourne, Victoria, Australia